Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis
Clinical trial NCT01262898 · COMPLETED
Trial details
- NCT number
- NCT01262898
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-03
- Primary completion
- 2013-02-26
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.